The Experts below are selected from a list of 282 Experts worldwide ranked by ideXlab platform
P Lees - One of the best experts on this subject based on the ideXlab platform.
-
influence of oxytetracycline on Carprofen pharmacodynamics and pharmacokinetics in calves
Journal of Veterinary Pharmacology and Therapeutics, 2013Co-Authors: C Brentnall, Zhangrui Cheng, Quintin Mckellar, P LeesAbstract:A tissue cage model of inflammation in calves was used to determine the pharmacokinetic and pharmacodynamic properties of individual Carprofen enantiomers, following the administration of the racemate. RS(±) Carprofen was administered subcutaneously both alone and in combination with intramuscularly administered oxytetracycline in a four‐period crossover study. Oxytetracycline did not influence the pharmacokinetics of R(−) and S(+) Carprofen enantiomers, except for a lower maximum concentration (Cmax) of S(+) Carprofen in serum after co‐administration with oxytetracycline. S(+) enantiomer means for area under the serum concentration–time curve (AUC0–96h were 136.9 and 128.3 μg·h/mL and means for the terminal half‐life (T½k10) were = 12.9 and 17.3 h for Carprofen alone and in combination with oxytetracycline, respectively. S(+) Carprofen AUC0–96h in both Carprofen treatments and T½k10 for Carprofen alone were lower (P < 0.05) than R(−) Carprofen values, indicating a small degree of enantioselectivity in the disposition of the enantiomers. Carprofen inhibition of serum thromboxane B2 ex vivo was small and significant only at a few sampling times, whereas in vivo exudate prostaglandin (PG)E2 synthesis inhibition was greater and achieved overall significance between 36 and 72 h (P < 0.05). Inhibition of PGE2 correlated with mean time to achieve maximum concentrations in exudate of 54 and 42 h for both Carprofen treatments for R(−) and S(+) enantiomers, respectively. Carprofen reduction of zymosan‐induced intradermal swelling was not statistically significant. These data provide a basis for the rational use of Carprofen with oxytetracycline in calves and indicate that no alteration to Carprofen dosage is required when the drugs are co‐administered.
-
pharmacodynamics and enantioselective pharmacokinetics of racemic Carprofen in the horse
Journal of Veterinary Pharmacology and Therapeutics, 2002Co-Authors: P Lees, F S Aliabadi, M F LandoniAbstract:Carprofen is a nonsteroidal anti-inflammatory drug of the 2-arylpropionate subclass. It contains a single chiral centre and exists in two enantiomeric forms. In this study rac-Carprofen, at two dosages, 0.7 and 4.0 mg/kg,and placebo were administered i.v. to six New Forest horses in a three period cross-over study. The concentration-time profiles were established for R(-) and S(+)-Carprofen for plasma and both inflamed (exudate) and noninflamed (transudate) tissue cage fluids. R(-)-Carprofen was the predominant enantiomer in all three fluids, as indicated by plasma area under the curve (AUC) values for R(-) and S(+)-Carprofen of 117.4 and 22.6 μg h/mL (low dose Carprofen) and 557.5 and 138.1 μg h/mL (high dose Carprofen) respectively. Penetration of both enantiomers into exudate was slow and limited and passage into transudate was even lower. The pharmacodynamics of rac-Carprofen was investigated at both the molecular level and in terms of the ability to suppress components of the tissue cage inflammatory response. Low dose Carprofen produced only moderate and transient inhibition of serum thromboxane (Tx)B 2 but failed to affect exudate prostaglandin (PG)E 2 concentrations, whilst suppression of exudate leukotriene (LT)B 4 and β-glucuronidase was not significant. High dose Carprofen produced greater and more persistent inhibition of serum TxB 2 and virtually abolished exudate PGE 2 synthesis. Some inhibition of LTB 4 and β-glucuronidase in exudate was also obtained. At both dosages rac-Carprofen reduced the swelling produced by intradermal bradykinin injection but only high dose Carprofen was anti-inflammatory as indicated by suppression of temperature rise over exudate tissue cages and neither dose affected leucocyte numbers in exudate. When considered in conjunction with previous data on Carprofen, the present findings indicate that Carprofen is not a selective inhibitor of cyclooxygenase (COX) isoenzymes, COX-1 and COX-2 in the horse, although it may show some preference for COX-2 inhibition. Because low dose Carprofen, which is the clinically recommended dosage, produces minimal inhibition of COX, it is likely to achieve its therapeutic effects at least partially through other pathways, possibly including weak to moderate inhibition of 5-lipoxygenase and of enzyme release. The good safety margin of Carprofen in clinical use might also be explained by weak COX inhibition and by other actions at the molecular level.
-
in vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and Carprofen
Research in Veterinary Science, 1999Co-Authors: Stephen P. Frean, L A Abraham, P LeesAbstract:Abstract The effects of hyaluronan and Carprofen (both racemic mixture and separate R and S enantiomers) on proteoglycan ( PG ) synthesis by equine cultured chondrocytes and cartilage explants were examined. Hyaluronan stimulated PG synthesis in both cell and explant cultures. The concentration–response curve of the latter was bell-shaped. Racemic Carprofen and R and S enantiomers also stimulated PG synthesis, although concentration–response relationships varied for each preparation and high concentrations inhibited synthesis. It was concluded that (a) hyaluronan exerts a stimulatory effect on PG synthesis at low concentrations and (b) stimulatory effects of Carprofen on PG synthesis are, to some degree, enantioselective with the Carprofen S-enantiomer exerting the greatest effect. Hyaluronan and Carprofen are used clinically despite incompletely understood mechanisms of action. These results suggest (a) hyaluronan and Carprofen might exert an anti-arthritic action through stimulation of PG synthesis and (b) there is possible justification for therapeutic administration of enantiomeric rather than racemic Carprofen.
-
pharmacodynamics and chiralpharmacokinetics of Carprofen in calves
British Veterinary Journal, 1996Co-Authors: P Delatour, P Lees, R Foot, A P Foster, D BaggoAbstract:Summary The non-steroidal anti-inflammatory drug, Carprofen, was administeredintravenously as the racemate at a dose rate of 0.7 mg kg−1 to six Friesian bull calves aged 8–10 weeks. Anti-inflammatory properties were indicated by attenuation of temperature rise at sites of intradermal injection of the irritants, carrageenin and dextran, but responses were not statistically significant at most recording times. Carrageenin- and dextran-induced swelling were not significantly reduced by Carprofen. Carprofen reduced ex vivo serum thromboxane B2 synthesis but this effect was also not significant at most sampling times. Enantioselective pharmacokinetics of Carprofen was demonstrated, plasma concentrations of the R(−) enantiomer predominating at all sampling times. It is concluded that inhibition of cyclo-oxygenase is unlikely to be the sole mechanism of action of Carprofen in calves.
-
evaluation of Carprofen in calves using atissue cage model of inflammation
British Veterinary Journal, 1996Co-Authors: P Lees, P Delatour, R Foot, A P Foster, D BaggoAbstract:Summary The arylpropionate anti-inflammatory drug, Carprofen, was administered intravenously as the racemate at a dose rate of 0.7 mg kg−1 body weight to six Friesian bull calves aged 16–17 weeks. Anti-inflammatory and pharmacokinetic properties were investigated using a tissue cage model of inflammation based on intracaveal injection of the mild irritant, carrageenin. Carprofen displayed enantioselective pharmacokinetics, with the R(−) enantiorner predominating in plasma at all measuring times. Elimination half-life and mean residence time were shorter and volume of distribution and clearance were greater for the S(+) than for the R(−) enantiomer. Penetration of both enantiomers into transudate (non-stimulated tissue cage) was poor but penetration into exudate (carrageenin-stimulated tissue cage) was good. Carprofen failed to reduce exudate concentration of prostaglandin E2 and the reductions in 12-hydroxyeicosatetraenoic acid were non-significant at most sampling times. The long elimination half-life of both R(−) and S(+) Carprofen enantiomers and their ready penetration into and slow clearance from inflammatory exudate indicate that the drug is likely to have a long duration of action in calves. The mechanism of action is unknown but it is unlikely to involve inhibition of either cyclooxygenase or 12-lipoxygenase.
Christian Burvenich - One of the best experts on this subject based on the ideXlab platform.
-
effect of Carprofen treatment following experimentally induced escherichia coli mastitis in primiparous cows
Journal of Dairy Science, 2005Co-Authors: Frederic Vangroenweghe, Luc Duchateau, Philippe Boutet, Pierre Lekeux, Pascal Rainard, Max Paape, Christian BurvenichAbstract:Abstract Acute Escherichia coli mastitis is one of the major sources of economic loss in the dairy industry due to reduced milk production, treatment costs, discarded milk, and occasional fatal disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as adjunctive therapy to antibiotics. The objective of the current study was to evaluate the effect of Carprofen treatment following infusion of Escherichia coli into the mammary glands of primiparous cows during the periparturient period. Severity of mastitis was scored based on the average milk production in the uninfected quarters on d +2 postinoculation and a clinical severity score. Carprofen was administered intravenously at 9h postchallenge, when clinical signs of mastitis appeared. In previous work, efficacy of NSAIDs was mainly evaluated using clinical symptoms. In the present study, the effect of Carprofen on innate immune response was also assessed by quantification of inflammatory mediators. All primiparous cows reacted as moderate responders throughout the experimental period. Primiparous cows were intramammarily inoculated with 1×10 4 cfu of E. coli P4:O32 in 2 left quarters. Analysis of blood and milk parameters, including IL-8, complement component C5a, lipopolysaccharide-binding protein (LBP), soluble CD14, prostaglandin E 2 , and thromboxane B 2 was performed from d 0 to d +6 relative to intramammary inoculation. Rectal temperature in Carprofen-treated animals was lower than in control animals at 3 and 6h posttreatment. Treatment also restored the decreased reticulorumen motility that occurs during E. coli mastitis to preinfection levels faster than in control animals. Carprofen treatment resulted in an earlier normalization of the clinical severity score. Eicosanoid (prostaglandin E 2 and thromboxane B 2 ) production in milk tended to be inhibited by Carprofen. No significant differences in the kinetic patterns of somatic cell count, IL-8, complement component C5a, LBP, and soluble CD14 were observed. In conclusion, Carprofen treatment improved general clinical condition by effective antipyrexia and restoration of reticulorumen motility but did not significantly inhibit eicosanoid production. Carprofen treatment did not result in a significant decrease of chemotactic inflammatory mediators, IL-8 and C5a, and early innate immune molecules, sCD14 and LBP. Therefore, major modulatory effects from NSAID administration were not observed in this mastitis model, although a larger study might confirm some apparent trends obtained in the present results.
-
Effect of Carprofen following experimentally induced E. coli mastitis in primiparous cows.
2005Co-Authors: Frederic Vangroenweghe, Luc Duchateau, Philippe Boutet, Pierre Lekeux, Pascal Rainard, Max Paape, R Bossuyt, Christian BurvenichAbstract:Acute Escherichia coli mastitis is one of the major sources of economic Loss in the dairy industry, due to reduced milk production, treatment costs, discarded milk and occasional fatal disease. Non-steroidal anti-inflammatory drugs (NSAID's) are frequently used as adjunctive therapy to antibiotics. The objective of the current study was to evaluate the effect of Carprofen treatment following infusion of E. coli into the mammary glands of primiparous cows during the periparturient period. Carprofen is a powerful inhibitor of inducible enzymes of the cyclo-oxygenase pathway. The study was conducted to GCP standard under veterinary supervision and complied with applicable animal welfare and regulatory requirements. Severity of mastitis was scored based on the average milk production in the uninfected quarters on d+2 post-inoculation. ALL heifers reacted as moderate responders. Carprofen was administered at 9 h post-challenge, when clinical signs of mastitis appeared. In previous work, efficacy of NSAID's was mainly evaluated using clinical symptoms. In the present study, the effect of Carprofen on innate immune response was also assessed by quantification of inflammatory mediators. Primiparous cows were intramammarily inoculated with 1 X 10(4) CFU E. coli P4:032 in two left quarters. Analysis of blood and milk parameters, including IL-8, C5a, LBP, sCD14, PGE(2) and TXB2. was performed from d0 to d+6 relative to intramammary inoculation. Rectal temperature in Carprofen-treated animals was lower than that of control animals 3 and 6 h post-treatment (P < 0.05). Treatment also restored the decreased reticulorumen motility that occurs during E. coli mastitis to pre-infection Levels faster than in control animals. Eicosanoid (PGE2 and TXB2) production in milk tended to be inhibited by Carprofen. No significant differences in the kinetic patterns of SCC, IL-8, C5a, LBP and sCD14 were observed. In conclusion, in this study Carprofen improved general clinical condition by effective antipyrexia and restoration of reticulorumen motility.
Masaki Otagiri - One of the best experts on this subject based on the ideXlab platform.
-
Stereoselective inhibition of carbonyl reductase from rabbit kidney by enantiomers of Carprofen.
Iubmb Life, 1994Co-Authors: Toshiyuki Higuchi, Yorishige Imamura, Masaki OtagiriAbstract:The inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney were examined. Of NSAIDs tested, only Carprofen exhibited a pronounced stereoselectivity for the inhibition of the purified enzyme; (-)-Carprofen inhibited more strongly the enzyme than three fold of its (+)-form. (-)-Carprofen was found to inhibit the enzyme noncompetitively with respect to acetohexamide and competitively with respect to NADPH. Similar modes were observed for the inhibition of the enzyme by (+)-Carprofen. The treatment of the apoenzyme with (-)-Carprofen led to a time- and concentration-dependent loss of the catalytic activity. Furthermore, NADP+ afforded a significant protection against inactivation of the enzyme by (-)-Carprofen. These results suggest that enantiomers of Carprofen bind to coenzyme-binding domain of the enzyme and cause the stereoselective inhibition of acetohexamide reduction by competing with NADPH.
-
study of interaction of Carprofen and its enantiomers with human serum albumin i mechanism of binding studied by dialysis and spectroscopic methods
Biochemical Pharmacology, 1993Co-Authors: Mohammed Habibur Rahman, Toru Maruyama, Tomoko Okada, Keishi Yamasaki, Masaki OtagiriAbstract:Abstract The binding of Carprofen, a non-steroidal anti-inflammatory drug of the aryl propionic acid class [2-(6-chlorocarbazole)propionic acid], and its enantiomers to human serum albumin (HSA) has been studied by dialysis and spectroscopic methods. Binding parameters obtained by different methods were in close agreement. The binding of Carprofen to HSA by both fluorescence and equilibrium dialysis (ED) methods is characterized by two sets of association constants [K1 = 5.1 × 106 M−1 (fluorescence) and 3.7 × 106M− (ED), K2 = 3.7 × 105M−1 (fluorescence) and 1.3 × 105 M−1 (ED)]. The S(+)-enantiomer of Carprofen showed slightly higher affinity for HSA than its corresponding antipode by both methods. Different analyses of the binding to HSA suggested the presence of one high affinity site and five to seven low affinity sites for Carprofen and its enantiomers on HSA. Fluorescence displacement data implied that Carprofen primarily binds to site II, the benzodiazepine site, while the low affinity site of Carprofen is site I, the warfarin site. Circular dichroism data suggested different mechanisms for the high affinity and the low affinity binding of Carprofen to HSA. The data are consistent with the major part of the binding energy at site II being electrostatic and hydrophobic interactions, whereas for the low affinity binding, hydrophobic interactions. Binding was exothermic, entropy driven and spontaneous, as indicated by the thermodynamic analyses. From binding data with chemically modified HSA derivatives, it is likely that tyrosine, lysine and histidine residues are especially involved in Carprofen binding to HSA, and it is most likely that the high affinity binding of Carprofen is located in the N-terminal part of domain III or that section of protein plus the C-terminal part of domain II of the HSA molecule. When the binding of Carprofen to HSA was compared to the binding of Carprofen methyl ester to HSA (K = 0.1 × 106M−1), the carboxyl group of Carprofen was found to play an important role especially in the high affinity binding of Carprofen to HSA. The high affinity of Carprofen to HSA was independent of the conformational changes on HSA caused by N-B transition.
-
Study of interaction of Carprofen and its enantiomers with human serum albumin—II: Stereoselective site-to-site displacement of Carprofen by ibuprofen
Biochemical Pharmacology, 1993Co-Authors: Mohammed Habibur Rahman, Toru Maruyama, Tomoko Okada, Teruko Imai, Masaki OtagiriAbstract:The site-to-site displacement of Carprofen, a site II-specific drug, bound to human serum albumin (HSA) by ibuprofen, another site II-specific drug, was qualitatively and quantitatively studied by circular dichroism (CD) and equilibrium dialysis (ED). Carprofen gives rise to different CD spectra at lower (1:1) and higher (3:1) molar ratios to HSA, indicating different mechanisms for the binding of this drug to its high and low affinity sites on HSA. Ibuprofen at a 5:1 molar ratio to HSA displaces Carprofen at a molar ratio of 1:1 to HSA from its high affinity binding site (site II) to its low affinity site (site I), as shown by production of the CD spectrum similar to that obtained in the case of the Carprofen-HSA complex at a molar ratio 3:1. As revealed by the ED experiments, the free fraction of Carprofen at a molar ratio of 1:2 to HSA (2 × 10−5M) was not initially increased by the addition of ibuprofen at a lower concentration, but at a higher concentration (6 × 10−5M), the free fraction was increased by only 90%. When site I was sufficiently blocked by a site I-specific drug like warfarin or phenylbutazone (6 × 10−5M), there was about a 4-fold increase in the free fraction of Carprofen caused by ibuprofen. This site-to-site displacement demonstrated by Carprofen was found to be stereospecific as indicated by the highest interaction between the S(+)-enantiomers of Carprofen and ibuprofen. Moreover, the displacement of Carprofen occurred at the azapropazone region rather than the warfarin region of site I on HSA.
Frederic Vangroenweghe - One of the best experts on this subject based on the ideXlab platform.
-
effect of Carprofen treatment following experimentally induced escherichia coli mastitis in primiparous cows
Journal of Dairy Science, 2005Co-Authors: Frederic Vangroenweghe, Luc Duchateau, Philippe Boutet, Pierre Lekeux, Pascal Rainard, Max Paape, Christian BurvenichAbstract:Abstract Acute Escherichia coli mastitis is one of the major sources of economic loss in the dairy industry due to reduced milk production, treatment costs, discarded milk, and occasional fatal disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as adjunctive therapy to antibiotics. The objective of the current study was to evaluate the effect of Carprofen treatment following infusion of Escherichia coli into the mammary glands of primiparous cows during the periparturient period. Severity of mastitis was scored based on the average milk production in the uninfected quarters on d +2 postinoculation and a clinical severity score. Carprofen was administered intravenously at 9h postchallenge, when clinical signs of mastitis appeared. In previous work, efficacy of NSAIDs was mainly evaluated using clinical symptoms. In the present study, the effect of Carprofen on innate immune response was also assessed by quantification of inflammatory mediators. All primiparous cows reacted as moderate responders throughout the experimental period. Primiparous cows were intramammarily inoculated with 1×10 4 cfu of E. coli P4:O32 in 2 left quarters. Analysis of blood and milk parameters, including IL-8, complement component C5a, lipopolysaccharide-binding protein (LBP), soluble CD14, prostaglandin E 2 , and thromboxane B 2 was performed from d 0 to d +6 relative to intramammary inoculation. Rectal temperature in Carprofen-treated animals was lower than in control animals at 3 and 6h posttreatment. Treatment also restored the decreased reticulorumen motility that occurs during E. coli mastitis to preinfection levels faster than in control animals. Carprofen treatment resulted in an earlier normalization of the clinical severity score. Eicosanoid (prostaglandin E 2 and thromboxane B 2 ) production in milk tended to be inhibited by Carprofen. No significant differences in the kinetic patterns of somatic cell count, IL-8, complement component C5a, LBP, and soluble CD14 were observed. In conclusion, Carprofen treatment improved general clinical condition by effective antipyrexia and restoration of reticulorumen motility but did not significantly inhibit eicosanoid production. Carprofen treatment did not result in a significant decrease of chemotactic inflammatory mediators, IL-8 and C5a, and early innate immune molecules, sCD14 and LBP. Therefore, major modulatory effects from NSAID administration were not observed in this mastitis model, although a larger study might confirm some apparent trends obtained in the present results.
-
Effect of Carprofen following experimentally induced E. coli mastitis in primiparous cows.
2005Co-Authors: Frederic Vangroenweghe, Luc Duchateau, Philippe Boutet, Pierre Lekeux, Pascal Rainard, Max Paape, R Bossuyt, Christian BurvenichAbstract:Acute Escherichia coli mastitis is one of the major sources of economic Loss in the dairy industry, due to reduced milk production, treatment costs, discarded milk and occasional fatal disease. Non-steroidal anti-inflammatory drugs (NSAID's) are frequently used as adjunctive therapy to antibiotics. The objective of the current study was to evaluate the effect of Carprofen treatment following infusion of E. coli into the mammary glands of primiparous cows during the periparturient period. Carprofen is a powerful inhibitor of inducible enzymes of the cyclo-oxygenase pathway. The study was conducted to GCP standard under veterinary supervision and complied with applicable animal welfare and regulatory requirements. Severity of mastitis was scored based on the average milk production in the uninfected quarters on d+2 post-inoculation. ALL heifers reacted as moderate responders. Carprofen was administered at 9 h post-challenge, when clinical signs of mastitis appeared. In previous work, efficacy of NSAID's was mainly evaluated using clinical symptoms. In the present study, the effect of Carprofen on innate immune response was also assessed by quantification of inflammatory mediators. Primiparous cows were intramammarily inoculated with 1 X 10(4) CFU E. coli P4:032 in two left quarters. Analysis of blood and milk parameters, including IL-8, C5a, LBP, sCD14, PGE(2) and TXB2. was performed from d0 to d+6 relative to intramammary inoculation. Rectal temperature in Carprofen-treated animals was lower than that of control animals 3 and 6 h post-treatment (P < 0.05). Treatment also restored the decreased reticulorumen motility that occurs during E. coli mastitis to pre-infection Levels faster than in control animals. Eicosanoid (PGE2 and TXB2) production in milk tended to be inhibited by Carprofen. No significant differences in the kinetic patterns of SCC, IL-8, C5a, LBP and sCD14 were observed. In conclusion, in this study Carprofen improved general clinical condition by effective antipyrexia and restoration of reticulorumen motility.
M Cavalli - One of the best experts on this subject based on the ideXlab platform.
-
cox 1 and cox 2 inhibition in horse blood by phenylbutazone flunixin Carprofen and meloxicam an in vitro analysis
Pharmacological Research, 2005Co-Authors: C Beretta, G Garavaglia, M CavalliAbstract:Abstract We report on the inhibitory activity of the NSAIDs meloxicam, Carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays. As expected, comparison of IC50 indicated that meloxicam and Carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined. However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (−41.2%) and Carprofen (−12.9%) had lower COX-2 selectivity than at IC50. We therefore propose that the selectivity of NSAIDs should be assessed at the 80% as well as 50% inhibition level.